Skip to Main Content

Author Details

Sopit Wongkham
1992
213
37
PMIDPaper TitleJournal TitlePublished Year
37743108Corrigendum to "Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis" [Biochim. Biophys. Acta Mol. Basis Dis. 1869 (5) (2023) 166694 (PMID: 36972768)].2024
37052887Revision of potential prognostic markers of cholangiocarcinoma for clinical practice.2023
37921263Combined analysis of secreted proteins and glycosylation identifies prognostic features in cholangiocarcinoma.2023
37813201Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight.2023
37576707γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus.2023
36972768Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis.2023
37026527Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.2023
37271322High glucose enhances the aggressiveness of lung adenocarcinoma via activating epidermal growth factor receptor/signal transducer and activator of transcription 3 pathways.2023
36883059Dense GM-CSFR-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients.2023
37454493BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines.2023
36562400Lactic acidosis induces metabolic and phenotypic reprogramming in cholangiocarcinoma cells via the upregulation of thrombospondin-1.2023
34843714Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment.Experimental Cell Research2022
36308362Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor.2022
36225633Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight.American Journal of Cancer Research (discontinued)2022
35635715HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner.FASEB J2022
35598658Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis.Life Sciences2022
34353198High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus.Nutrition and Cancer2022
35337815Multiple actions of NMS-P715, the monopolar spindle 1 (MPS1) mitotic checkpoint inhibitor in liver fluke-associated cholangiocarcinoma cells.European Journal of Pharmacology2022
35225485Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.2022
34948304Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.International Journal of Molecular Sciences2021
34066878A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Agglutinin.Molecules2021
33737613Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma.Scientific Reports2021
33997388FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients.Heliyon2021
33777535Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma.PeerJ2021
33513399High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.Life Sciences2021
33450849High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways.Biomedicines2021
34036430High glucose: an emerging association between diabetes mellitus and cancer progression.Journal of Molecular Medicine2021
34035223Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.Cell Death and Disease2021
33505802Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells.PeerJ2021
33763382Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells.Frontiers in Oncology2021
33141432High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8.Cancer Science2021
33218924Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication.2021
33402473Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.In Vivo2021
34688691FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.Life Sciences2021
34504109Cholangiocarcinoma.Nature Reviews Disease Primers2021
34494080Overexpression of AGR2vH, an oncogenic AGR2 spliced transcript, potentiates tumorigenicity and proteomic alterations in cholangiocarcinoma cell.Bioscience, Biotechnology and Biochemistry2021
32659223Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.Clinica Chimica Acta2020
32020235Periostin induces epithelial⿿to⿿mesenchymal transition via the integrin α5β1/TWIST⿿2 axis in cholangiocarcinoma.Oncology Reports2020
32124934Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1â¿¿related antiâ¿¿apoptotic proteins.International Journal of Molecular Medicine2020
31894252Upregulation of AGR2vH facilitates cholangiocarcinoma cell survival under endoplasmic reticulum stress via the activation of the unfolded protein response pathway.International Journal of Molecular Medicine2020
31729681CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.Cellular oncology (Dordrecht)2020
32213588Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycans.Proc Natl Acad Sci U S A2020
32039582Deep Structural Analysis and Quantitation of O-Linked Glycans on Cell Membrane Reveal High Abundances and Distinct Glycomic Profiles Associated with Cell Type and Stages of Differentiation.Analytical Chemistry2020
31868214The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.Glycobiology2020
32207095Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient.Human Cell2020
32878800Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.Anticancer Research2020
33038372NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.Life Sci2020
33242709Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells.International Immunopharmacology2020
32782567Enhancement of piperlongumine chemosensitivity by silencing heme oxygenase-1 expression in cholangiocarcinoma cell lines.Oncology Letters2020
32664187Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients.Biomolecules2020
  • 1 - 50 of 213

Recommended Authors

Collaborators

Co-authored papers 26
Co-authored papers 7
Co-authored papers 5
Co-authored papers 5
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
International Research Center for Medical Sciences (IRCMS), Kumamoto University
Co-authored papers 1
Kurume University School of Medicine
Co-authored papers 1
Moores Cancer Center, university of california san diego
Co-authored papers 1
Heidelberg University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
California Institute of Technology
Co-authored papers 1
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Co-authored papers 1
University of Science and Technology Liaoning
Co-authored papers 1